Exelixis, Inc. (NASDAQ:EXEL) Q4 2025 Earnings Call Transcript February 10, 2026 Exelixis, Inc. beats earnings expectations. Reported EPS is $0.94, expectations were $0.77. Operator: Good day, ladies ...

The president’s recent push to send federal health care dollars directly to individuals, rather than insurers, reflects a ...

Fiscal 2026 Quarterly Outlook -- Net sales projected at $32 million to $35 million, operating expenses expected to increase slightly from the first quarter, and net loss per diluted share guided to a ...

The concept of non GamStop casinos has generated ongoing conversation in the UK’s gambling regulation space—mostly because they sit outside the government’s official self-exclusion ecosystem. GamStop, ...

Family background continues to strongly shape social and economic outcomes in Africa. More than 85% of young African workers hold informal and vulnerable jobs with limited mobility. The ILO links ...

The leaders of three major immigration agencies defended the Trump administration's deportations in testimony before lawmakers on Tuesday.

In this new era of cybersecurity driven by advanced data analytics, automation and AI, Qualys is pioneering a new risk ...

Please note that during today's call, system sales and operating profit growth will exclude the impact of foreign currency.

Objective To compare the diagnostic accuracy of minipad collected menstrual blood versus clinician collected cervical samples to test for human papillomavirus (HPV) in the detection of cervical ...

Twenty years after the introduction of the theory, we revisit what it does—and doesn’t—explain. by Clayton M. Christensen, Michael E. Raynor and Rory McDonald Please enjoy this HBR Classic. Clayton M.